2001
DOI: 10.1124/mol.59.5.965
|View full text |Cite
|
Sign up to set email alerts
|

BAY36-7620: A Potent Non-Competitive mGlu1 Receptor Antagonist with Inverse Agonist Activity.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

11
124
1

Year Published

2004
2004
2017
2017

Publication Types

Select...
6
3
1

Relationship

1
9

Authors

Journals

citations
Cited by 164 publications
(136 citation statements)
references
References 32 publications
11
124
1
Order By: Relevance
“…Firstly, several non-competitive antagonists that have been identified in pharmaceutical industries and found to interact in the HD of these receptors, act as inverse agonists, probably by directly stabilizing the inactive state of the HD. This is the case for the mGlu1 selective antagonist BAY36-7620 ((3aS,6aS)-6a-Naphtalen-2-ylmethyl-5-methylidenhexahydro-cyclopental[c]furan-1-on) (Carroll et al, 2001), and for the mGlu5 selective antagonist MPEP (2-methyl-6-(phenylethynyl)pyridine) (Pagano et al, 2000). Secondly, if the HD is really at the origin of the constitutive activity of these receptors, such activity may also be measurable with the a receptor truncated of the large ECD.…”
Section: The Heptahelical Domain Of Group-i Mglurs Displays Constitutmentioning
confidence: 99%
“…Firstly, several non-competitive antagonists that have been identified in pharmaceutical industries and found to interact in the HD of these receptors, act as inverse agonists, probably by directly stabilizing the inactive state of the HD. This is the case for the mGlu1 selective antagonist BAY36-7620 ((3aS,6aS)-6a-Naphtalen-2-ylmethyl-5-methylidenhexahydro-cyclopental[c]furan-1-on) (Carroll et al, 2001), and for the mGlu5 selective antagonist MPEP (2-methyl-6-(phenylethynyl)pyridine) (Pagano et al, 2000). Secondly, if the HD is really at the origin of the constitutive activity of these receptors, such activity may also be measurable with the a receptor truncated of the large ECD.…”
Section: The Heptahelical Domain Of Group-i Mglurs Displays Constitutmentioning
confidence: 99%
“…Such compounds act either as non-competitive antagonists (32)(33)(34) or as positive allosteric modulators (35)(36)(37)(38)(39)(40). In each case, these compounds have been shown to bind within the HD of their targeted receptor (34,(41)(42)(43).…”
mentioning
confidence: 99%
“…This process results in receptor activation (Costantino et al 1999;Rondard and Pin 2015;Takahashi et al 1993). The other binding site, for positive and negative allosteric modulators, is located within the 7TM domain (Carroll et al 2001;Gregory and Conn 2015;Litschig et al 1999). Binding of a negative allosteric modulator to this site results in non-competitive inhibition of the receptor.…”
Section: Pharmacologymentioning
confidence: 99%